Sick Funds Forum: Drug Spend Management 2020/21


Payers will present their thoughts on the influence of digitisation, high-priced therapies and patient access on drug expenditures management in Germany's statutory health insurance GKV in times of the Covid-19 pandemic. What changes will come in 2020/21?


Online conference


More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.


an initial 10 day temporary access of APM Health Europe.